Vanguard Portfolio Management’s Starling Oncology Institute, Inc. Common Stock STLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.65M Buy
+862,839
New +$2.65M ﹤0.01% 2520

Other funds holding STLN

Vanguard Portfolio Management's STLN Position: Q1 2026 in Review

Vanguard Portfolio Management opened a new position in Starling Oncology Institute, Inc. Common Stock (STLN) in Q1 2026: 862,839 shares worth $2.65M. The stake represents ﹤0.01% of the portfolio and ranks #2520 among its holdings.

115 funds tracked by Wall St. Rank hold STLN as of Q1 2026.

  • Vanguard Portfolio Management held 862,839 shares of Starling Oncology Institute, Inc. Common Stock worth $2.65M as of Q1 2026.
  • Starling Oncology Institute, Inc. Common Stock was a new Vanguard Portfolio Management position in Q1 2026.
  • Starling Oncology Institute, Inc. Common Stock made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q1 2026, its #2520 holding.
  • 115 funds tracked by Wall St. Rank held Starling Oncology Institute, Inc. Common Stock as of Q1 2026.

Based on Vanguard Portfolio Management's 13F filing for Q1 2026, filed 8 May 2026.